MR [Mindray Medical International] 6-K: Mindray Announces Receipt of Revised Non-binding Proposal to
[Mindray Announces Receipt of Revised Non-binding Proposal to Acquire the Company at US$27 per ADS or US$27 per Ordinary Share The special committee of the Board (the “Special Committee”), formed to consider the original proposal by the Buyer Group, is evaluating this revised proposal with the assistance of its financial and legal advisors. The Special Committee cautions the Company’s shareholders] []